Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Richard Malamut

Director at Pelthos Therapeutics Inc. (PTHS)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $12K

Reported trades

Filed Stock Type Shares Price Value Since
Apr 6SEC PTHSPelthos Therapeutics Inc. Sell Plan 31027,702 held (−1%) $20.51 $6K -1.8%
Apr 6SEC PTHSPelthos Therapeutics Inc. Sell Plan 28027,422 held (−1%) $21.36 $6K -5.7%
  • Sell

    Director Richard Malamut sold $6K of PTHS at $20.51 — pre-scheduled 10b5-1 plan sale.

  • Sell

    Director Richard Malamut sold $6K of PTHS at $21.36 — pre-scheduled 10b5-1 plan sale.